All Articles

Attovia Therapeutics’ successful IPO injects massive capital into its ambitious pipeline, but can its novel multi-specific antibody platform outmaneuver giants?

UNISOC's new AI audio suite isn't just about clearer calls. It's a strategic move using on-device AI to reshape device design, cost, and connectivity.

xSuite's new leadership nod from QKS Group isn't just a win; it signals a market shift where AI agents are taking control of AP, moving beyond automation.

Chinese giant TAILG isn't just selling e-scooters in Bangladesh; it's deploying a localized strategy with sodium-ion batteries to solve real urban challenges.

MasterCraft's pontoon brands are integrating Apple CarPlay with Savvy Navvy. We analyze the strategy, the execution, and what it means for the industry.

Despite a revenue dip, Glacier Media's strategic exit from print has ignited a stunning return to profitability, signaling a new era for the data-driven firm.

The silicon giant reports a stunning return to profitability, but a deep dive reveals a massive one-time energy contract gain, not just operational muscle.

Unpacking AFG's stellar Q2 results reveals a potent mix of underwriting discipline and strategic capital plays that set it apart from the competition.

Midland States Bancorp's 26th straight dividend increase isn't just a number; it's a carefully crafted message about resilience and long-term value.

As Aspen Aerogels prepares for a key investor conference, its leadership will detail a strategy balancing market headwinds with its critical role in EV safety.

PAMT CORP's Q2 loss masks significant operational gains. Tech-driven efficiency and rising freight rates signal a potential industry shift. What's next?

Jonathan Baum's ABA award isn't just a trophy. It's the culmination of a 30-year mission that embedded pro bono service into the DNA of a major law firm.

Celanese reports its best quarter in three years, driven by aggressive cost-cutting and operational agility. But can this momentum hold against industry headwinds?

IFF sheds its Food Ingredients unit to focus on high-margin innovation in Taste, Scent, and Health, unlocking a multi-billion dollar capital return plan.

Editas Medicine’s new board member signals a sharp focus on cardiovascular disease, a strategic pivot that could reshape the competitive gene editing race.

AGNT, Inc. posts record revenue and agent growth, but a net loss lingers. We analyze its strategic pivot, the NextHome acquisition, and its complex path forward.

CompX defies market headwinds with a 41% surge in operating income. A deep dive into the strategic pivots in security and marine that are driving success.

GAMCO Investors reports impressive growth, but its true story lies in a fortress-like balance sheet and a classic strategy thriving in the age of AI.

With a new CEO at the helm and a strategic review underway, Rayonier Advanced Materials seeks to unlock value in its core business while battling market headwinds.

With a fortified balance sheet and a strategic pivot, OnKure Therapeutics is betting that precision and selectivity will conquer a competitive drug market.